STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
Read the full articleYou might also wanna read
Proposed NIH Budget Cuts Threaten HIV Breakthroughs Like Lenacapavir, Article Argues
Biomedical advances such as lenacapavir depend on years of publicly funded basic research
thinkglobalhealth.org·28d agoGlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company
Creates a new focused HIV business with the sustainability to deliver significant improvements in treatment, access and shareholder value.
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Conditions : HIV-1-infection Interventions : Drug: Lenacapavir; Drug: Lenacapavir Tablet; Drug: Teropavimab; Drug: Zinlirvimab; Drug: SBR Sp
Global Health Watch: New Political Declaration on HIV/AIDS, End of US PEPFAR Support for South Africa + Treatment Declines
UN member states adopted a new Political Declaration on HIV/AIDS reaffirming global commitments to end AIDS by 2030, but for the first time
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Conditions : HIV Infections Interventions : Drug: Lenacapavir; Drug: Lenacapavir Tablet; Drug: Teropavimab; Drug: Zinlirvimab; Drug: Caboteg
Rep. Mike Turner: COVID vaccines brought to you by capitalism -- innovation is worth protecting
Rep. Mike Turner: COVID vaccines brought to you by capitalism -- innovation is worth protecting Published on FOX Business on May 7, 2021 In
Comments
Sign in to join the conversation.
No comments yet. Be the first.